|
1
|
Maitra A and Hruban RH: Pancreatic cancer.
Annu Rev Pathol. 3:157–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pekala KR, Ma X, Kropp PA, Petersen CP,
Hudgens CW, Chung CH, Shi C, Merchant NB, Maitra A, Means AL and
Gannon MA: Loss of HNF6 expression correlates with human pancreatic
cancer progression. Lab Invest. 94:517–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Murray T, Samuels A, Ghafoor A,
Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin.
53:5–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y, Ma W and Zheng W: Deguelin, a
novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest
and anti-angiogenesis for cancer chemoprevention. Mol Clin Oncol.
1:215–219. 2013.PubMed/NCBI
|
|
5
|
Mehta R, Katta H, Alimirah F, Patel R,
Murillo G, Peng X, Muzzio M and Mehta RG: Deguelin action involves
c-Met and EGFR signaling pathways in triple negative breast cancer
cells. PLoS One. 8:e651132013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee H, Lee JH, Jung KH and Hong SS:
Deguelin promotes apoptosis and inhibits angiogenesis of gastric
cancer. Oncol Rep. 24:957–963. 2010.PubMed/NCBI
|
|
7
|
Hu J, Ye H, Fu A, Chen X, Wang Y, Chen X,
Ye X, Xiao W, Duan X, Wei Y and Chen L: Deguelin - an inhibitor to
tumor lymphangiogenesis and lymphatic metastasis by downregulation
of vascular endothelial cell growth factor-D in lung tumor model.
Int J Cancer. 127:2455–2466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mehta RR, Katta H, Kalra A, Patel R, Gupta
A, Alimirah F, Murillo G, Peng X, Unni A, Muzzio M and Mehta RG:
Efficacy and mechanism of action of Deguelin in suppressing
metastasis of 4T1 cells. Clin Exp Metastasis. 30:855–866. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adolphe C, Narang M, Ellis T, Wicking C,
Kaur P and Wainwright B: An in vivo comparative study of sonic,
desert and Indian hedgehog reveals that hedgehog pathway activity
regulates epidermal stem cell homeostasis. Development.
131:5009–5019. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pathi S, PaganWestphal S, Baker DP, Garber
EA, Rayhorn P, Bumcrot D, Tabin CJ, Blake Pepinsky R and Williams
KP: Comparative biological responses to human Sonic, Indian and
Desert hedgehog. Mech Dev. 106:107–117. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang XM, RamalhoSantos M and McMahon AP:
Smoothened mutants reveal redundant roles for Shh and Ihh signaling
including regulation of L/R asymmetry by the mouse node. Cell.
105:781–792. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y and Struhl G: Dual roles for
patched in sequestering and transducing Hedgehog. Cell. 87:553–563.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McMahon AP, Ingham PW and Tabin CJ:
Developmental roles and clinical significance of hedgehog
signaling. Curr Top Dev Biol. 53:1–114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Motoyama J, Liu J, Mo R, Ding Q, Post M
and Hui CC: Essential function of Gli2 and Gli3 in the formation of
lung, trachea and oesophagus. Nat Genet. 20:54–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Motoyama J, Takabatake T, Takeshima K and
Hui C: Ptch2, a second mouse Patched gene is co-expressed with
Sonic hedgehog. Nat Genet. 18:104–106. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Smyth I, Narang MA, Evans T, Heimann C,
Nakamura Y, ChenevixTrench G, Pietsch T, Wicking C and Wainwright
BJ: Isolation and characterization of human patched 2 (PTCH2), a
putative tumour suppressor gene in basal cell carcinoma and
medulloblastoma on chromosome 1p32. Hum Mol Genet. 8:291–297. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stone DM, Hynes M, Armanini M, Swanson TA,
Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, et
al: The tumour-suppressor gene patched encodes a candidate receptor
for Sonic hedgehog. Nature. 384:129–134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barnfield PC, Zhang X, Thanabalasingham V,
Yoshida M and Hui CC: Negative regulation of Gli1 and Gli2
activator function by Suppressor of fused through multiple
mechanisms. Differentiation. 73:397–405. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Méthot N and Basler K: Suppressor of fused
opposes hedgehog signal transduction by impeding nuclear
accumulation of the activator form of Cubitus interruptus.
Development. 127:4001–4010. 2000.PubMed/NCBI
|
|
21
|
Matsushita S, Onishi H, Nakano K,
Nagamatsu I, Imaizumi A, Hattori M, Oda Y, Tanaka M and Katano M:
Hedgehog signaling pathway is a potential therapeutic target for
gallbladder cancer. Cancer Sci. 105:272–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Freije JM, Balbin M, Pendás AM, Sánchez
LM, Puente XS and López-Otín C: Matrix metalloproteinases and tumor
progression. Adv Exp Med Biol. 532:91–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vihinen P, AlaAho R and Kähäri VM: Matrix
metalloproteinases as therapeutic targets in cancer. Curr Cancer
Drug Targets. 5:203–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karhadkar SS, Bova GS, Abdallah N, Dhara
S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA:
Hedgehog signalling in prostate regeneration, neoplasia and
metastasis. Nature. 431:707–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao X, Siu MK, Au CW, Wong ES, Chan HY,
Ip PP, Ngan HY and Cheung AN: Aberrant activation of hedgehog
signaling pathway in ovarian cancers: effect on prognosis, cell
invasion and differentiation. Carcinogenesis. 30:131–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mori Y, Okumura T, Tsunoda S, Sakai Y and
Shimada Y: Gli-1 expression is associated with lymph node
metastasis and tumor progression in esophageal squamous cell
carcinoma. Oncology. 70:378–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoo YA, Kang MH, Kim JS and Oh SC: Sonic
hedgehog signaling promotes motility and invasiveness of gastric
cancer cells through TGF-beta-mediated activation of the ALK5-Smad
3 pathway. Carcinogenesis. 29:480–490. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li SH, Fu J, Watkins DN, Srivastava RK and
Shankar S: Sulforaphane regulates self-renewal of pancreatic cancer
stem cells through the modulation of Sonic hedgehog-GLI pathway.
Mol Cell Biochem. 373:217–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rodova M, Fu J, Watkins DN, Srivastava RK
and Shankar S: Sonic hedgehog signaling inhibition provides
opportunities for targeted therapy by sulforaphane in regulating
pancreatic cancer stem cell self-renewal. PLoS One. 7:e460832012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
HadlerOlsen E, Winberg JO and Uhlin-Hansen
L: Matrix metalloproteinases in cancer: their value as diagnostic
and prognostic markers and therapeutic targets. Tumour Biol.
34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
StetlerStevenson WG: Type IV collagenases
in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen JS, Li HS, Huang JQ, Zhang LJ, Chen
XL, Wang Q, Lei J, Feng JT, Liu Q and Huang XH: Down-regulation of
Gli-1 inhibits hepatocellular carcinoma cell migration and
invasion. Mol Cell Biochem. 393:283–291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen M, Qian Y, Dai J and Chu R: The sonic
hedgehog signaling pathway induces myopic development by activating
matrix metalloproteinase (MMP)-2 in Guinea pigs. PLoS One.
9:e969522014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fan HX, Wang S, Zhao H, Liu N, Chen D, Sun
M and Zheng JH: Sonic hedgehog signaling may promote invasion and
metastasis of oral squamous cell carcinoma by activating MMP-9 and
E-cadherin expression. Med Oncol. 31:412014. View Article : Google Scholar : PubMed/NCBI
|
